Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor

Fernadez-Galar, M. (Marta); España, A. (Agustín); Lopez-Picazo, J.M. (José M.)

Authors:

Fernadez-Galar, M. (Marta)

España, A. (Agustín)

Lopez-Picazo, J.M. (José M.)

Keywords:

Antineoplastic Agents/adverse effects
Lung Neoplasms/drug therapy
Adenocarcinoma/drug therapy

Issue Date:

2003

Publisher:

Wiley-Blackwell

Publisher Version:

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2230.2004.01466.x/pdf

ISSN:

0307-6938

Citation:

Fernandez-Galar M, España A, López-Picazo JM. Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor . Clin Exp Dermatol. 2004 Mar;29(2):138-40.

Abstract

Drugs that inhibit the epidermal growth factor receptor, such as ZD1839 or C225, are being used increasingly in the treatment of solid tumours. This has led to the appearance of new secondary effects. We describe the case of a patient who presented with an acneiform eruption secondary to the administration of ZD1839. These lesions healed in a few days after stopping the drug

URI:

https://hdl.handle.net/10171/23818

Appears in Collections:

DA - CUN - Dermatología médico-quirúrgica y venereológica - Artículos de revista
DA - CUN - Oncología médica - Artículos de revista

Files in This Item: